Abstract
Neurosteroids play essential roles in the control of central nervous system functions during physiological and pathological conditions. Increasing evidences show gender differences in the pathogenesis and clinical manifestations of several neurodevelopmental conditions, including Autism Spectrum Disorders (ASD), possibly due to the action of sex hormones during critical periods of brain development. Furthermore, it is known that neuroactive steroids contribute to neuroprotection, spinogenesis, synaptogenesis, as well as to modulation of neuronal excitability via their interaction with GABA receptors. Dysfunctions of GABAergic signaling early in development lead to a severe excitation-inhibition unbalance in neuronal circuits, which may contribute to the pathophysiology of autism.
In this review, we summarize recent data concerning the functional role of neurosteroids and their relationship with the GABAergic system, focusing on GABA-mediated neurotrasmission alterations characterizing some neurodevelopmental disorders.
Keywords: Brain sexual dimorphism, neurosteroids, neurodevelopmental disorders, GABA receptors, autism, synaptic plasticity, estrogen, androgen.
Current Pharmaceutical Design
Title:Focusing on the Interactions between the GABAergic System and Neurosteroids in Neurodevelopmental Disorders
Volume: 19 Issue: 36
Author(s): Francesca Fanelli, Ramona Marino and Flavio Keller
Affiliation:
Keywords: Brain sexual dimorphism, neurosteroids, neurodevelopmental disorders, GABA receptors, autism, synaptic plasticity, estrogen, androgen.
Abstract: Neurosteroids play essential roles in the control of central nervous system functions during physiological and pathological conditions. Increasing evidences show gender differences in the pathogenesis and clinical manifestations of several neurodevelopmental conditions, including Autism Spectrum Disorders (ASD), possibly due to the action of sex hormones during critical periods of brain development. Furthermore, it is known that neuroactive steroids contribute to neuroprotection, spinogenesis, synaptogenesis, as well as to modulation of neuronal excitability via their interaction with GABA receptors. Dysfunctions of GABAergic signaling early in development lead to a severe excitation-inhibition unbalance in neuronal circuits, which may contribute to the pathophysiology of autism.
In this review, we summarize recent data concerning the functional role of neurosteroids and their relationship with the GABAergic system, focusing on GABA-mediated neurotrasmission alterations characterizing some neurodevelopmental disorders.
Export Options
About this article
Cite this article as:
Fanelli Francesca, Marino Ramona and Keller Flavio, Focusing on the Interactions between the GABAergic System and Neurosteroids in Neurodevelopmental Disorders, Current Pharmaceutical Design 2013; 19 (36) . https://dx.doi.org/10.2174/1381612811319360009
DOI https://dx.doi.org/10.2174/1381612811319360009 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Design of Multi-target Drugs to Treat Cardiovascular Diseases: Two
(or more) Birds on One Stone
Current Topics in Medicinal Chemistry Approaching Inherited Disease on a Genomic Scale
Current Genomics Cannabis sativa L. Constituents and Their Role in Neuroinflammation
Current Bioactive Compounds Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer’s Disease Patients
Current Alzheimer Research Medications Acting on the GABA System in the Treatment of Alcoholic Patients
Current Pharmaceutical Design Editorial (Thematic Issue: Global Trends in Nanotechnological Approaches for Various Health Issues – Volume II)
Current Drug Metabolism Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases
Current Topics in Medicinal Chemistry Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry Lifelong Endocrine Fluctuations and Related Cognitive Disorders
Current Pharmaceutical Design Insights into Anti-Trypanosomal Agents Based on Synthetic Glycoconjugates
Current Topics in Medicinal Chemistry The Safety of Medications for the Treatment of Bipolar Disorder During Pregnancy and the Puerperium
Current Drug Safety GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design Nicotine, Lung and Cancer
Anti-Cancer Agents in Medicinal Chemistry Activators and Inhibitors of the Ion Channel of the NMDA Receptor
Current Drug Targets Histamine H3 Receptor Function and Ligands: Recent Developments
Mini-Reviews in Medicinal Chemistry High Throughput Screening Methodologies Classified for Major Drug Target Classes According to Target Signaling Pathways
Combinatorial Chemistry & High Throughput Screening Psychobiological Model of Personality: Guidelines for Pharmacotherapy of Personality Disorder
Current Psychopharmacology Metabolic Changes in Rat Plasma After Epilepsy by UPLC-MS/MS
Current Pharmaceutical Analysis The Role of Calcium Stores in Apoptosis and Autophagy
Current Molecular Medicine The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry